Improving Bioavailability using PBPK Modeling & Parallel Formulation Screening
Summary: A team of bioavailability experts at Catalent used the in-house bioavailability enhancement platform, OptiForm® Solution Suite, to optimize and develop Phase 1 clinical formulation within a short timeline. Catalent’s global supply chain expertise was utilized for packaging and distributing clinical supplies to the site and, as a result, the target molecule went from early stage to Phase 1 in under nine months.